Statistical Distributions
-
Subject Areas on Research
- A computer simulated phantom study of tomotherapy dose optimization based on probability density functions (PDF) and potential errors caused by low reproducibility of PDF.
- A genomic screen of autism: evidence for a multilocus etiology.
- A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.
- Aging and recognition memory: changes in regional cerebral blood flow associated with components of reaction time distributions.
- An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
- Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution.
- Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.
- Evolutionary dynamics of tumor progression with random fitness values.
- Expiry dates.
- Fixed and random effects selection in linear and logistic models
- Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout.
- Interpretation of simultaneous linkage and family-based association tests in genome screens.
- Joint Bayesian analysis of birthweight and censored gestational age using finite mixture models.
- Joint modeling of sensitivity and specificity.
- Molprobity's ultimate rotamer-library distributions for model validation.
- Nonparametric bayes testing of changes in a response distribution with an ordinal predictor.
- Optimal estimation for regression models on τ-year survival probability.
- Reproducibility of interfraction lung motion probability distribution function using dynamic MRI: statistical analysis.
- The uneven distribution of kidney transplants: getting at the root causes and improving care.
- Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.